Schonfeld Strategic Advisors LLC Neurocrine Biosciences Inc Transaction History

Schonfeld Strategic Advisors LLC

  • $15.2 Billion
  • Q3 2025

A detailed history of Schonfeld Strategic Advisors LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 77,693 shares of NBIX stock, worth $11.3 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
77,693
Previous 72,945 6.51%
Holding current value
$11.3 Million
Previous $9.17 Million 18.96%
% of portfolio
0.07%
Previous 0.07%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$123.98 - $146.67 $588,657 - $696,389
4,748 Added 6.51%
77,693 $10.9 Million
Q2 2025

Aug 14, 2025
BUY
$87.54 - $128.18 $5.76 Million - $8.43 Million
65,782 Added 918.36%
72,945 $9.17 Million
Q1 2025

May 15, 2025
SELL
$107.22 - $153.29 $3,967 - $5,671
-37 Reduced 0.51%
7,163 $792,000
Q4 2024

Feb 14, 2025
SELL
$111.62 - $139.44 $1.91 Million - $2.38 Million
-17,082 Reduced 70.35%
7,200 $982,000
Q3 2024

Nov 14, 2024
SELL
$114.58 - $153.15 $702,489 - $938,962
-6,131 Reduced 20.16%
24,282 $2.8 Million
Q2 2024

Aug 14, 2024
SELL
$130.86 - $143.19 $2.26 Million - $2.47 Million
-17,281 Reduced 36.23%
30,413 $4.19 Million
Q1 2024

May 15, 2024
SELL
$130.4 - $143.74 $10.5 Million - $11.6 Million
-80,675 Reduced 62.85%
47,694 $6.58 Million
Q4 2023

Feb 14, 2024
BUY
$106.07 - $132.76 $10.5 Million - $13.2 Million
99,360 Added 342.51%
128,369 $16.9 Million
Q3 2023

Nov 14, 2023
SELL
$94.02 - $117.1 $1.21 Million - $1.51 Million
-12,895 Reduced 30.77%
29,009 $3.26 Million
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $4.68 Million - $5.48 Million
-52,258 Reduced 55.5%
41,904 $3.95 Million
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $4.38 Million - $5.73 Million
46,562 Added 97.82%
94,162 $9.53 Million
Q4 2022

Feb 14, 2023
SELL
$106.72 - $127.06 $2.33 Million - $2.78 Million
-21,843 Reduced 31.45%
47,600 $5.69 Million
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $3.01 Million - $3.53 Million
32,722 Added 89.11%
69,443 $7.38 Million
Q2 2022

Aug 15, 2022
SELL
$75.79 - $100.07 $2.8 Million - $3.7 Million
-36,986 Reduced 50.18%
36,721 $3.58 Million
Q1 2022

May 16, 2022
SELL
$72.45 - $94.81 $3.44 Million - $4.5 Million
-47,511 Reduced 39.19%
73,707 $6.91 Million
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $9.66 Million - $12.9 Million
121,218 New
121,218 $10.3 Million
Q3 2021

Nov 16, 2021
SELL
$86.18 - $99.03 $1.71 Million - $1.96 Million
-19,800 Closed
0 $0
Q2 2021

Nov 16, 2021
SELL
$89.43 - $102.27 $44,715 - $51,135
-500 Reduced 2.46%
19,800 $1.93 Million
Q2 2021

Aug 16, 2021
BUY
$89.43 - $102.27 $1.82 Million - $2.08 Million
20,300 New
20,300 $1.98 Million
Q4 2020

Feb 16, 2021
SELL
$86.91 - $108.33 $3.18 Million - $3.96 Million
-36,551 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $3.04 Million - $4.27 Million
31,592 Added 637.06%
36,551 $4,000
Q2 2020

Aug 14, 2020
BUY
$85.09 - $130.36 $209,151 - $320,424
2,458 Added 98.28%
4,959 $605,000
Q1 2020

May 15, 2020
SELL
$75.11 - $113.76 $1.67 Million - $2.52 Million
-22,183 Reduced 89.87%
2,501 $216,000
Q4 2019

Feb 14, 2020
SELL
$86.8 - $118.57 $3.42 Million - $4.67 Million
-39,416 Reduced 61.49%
24,684 $2.65 Million
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $2.2 Million - $2.66 Million
26,200 Added 69.13%
64,100 $5.78 Million
Q2 2019

Aug 14, 2019
SELL
$72.24 - $91.27 $1.18 Million - $1.5 Million
-16,400 Reduced 30.2%
37,900 $3.2 Million
Q1 2019

May 15, 2019
SELL
$69.31 - $91.53 $3.43 Million - $4.53 Million
-49,489 Reduced 47.68%
54,300 $4.78 Million
Q4 2018

Feb 14, 2019
BUY
$68.32 - $124.36 $3.67 Million - $6.69 Million
53,789 Added 107.58%
103,789 $7.41 Million
Q3 2018

Nov 14, 2018
SELL
$98.88 - $125.85 $494,400 - $629,250
-5,000 Reduced 9.09%
50,000 $6.15 Million
Q2 2018

Aug 14, 2018
BUY
$75.3 - $105.99 $1.49 Million - $2.1 Million
19,793 Added 56.22%
55,000 $5.4 Million
Q1 2018

May 15, 2018
BUY
$75.88 - $92.43 $321,579 - $391,718
4,238 Added 13.68%
35,207 $2.92 Million
Q4 2017

Feb 14, 2018
SELL
$58.53 - $77.59 $1.45 Million - $1.92 Million
-24,711 Reduced 44.38%
30,969 $2.4 Million
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $2.67 Million - $3.41 Million
55,680
55,680 $3.41 Million

Others Institutions Holding NBIX

# of Institutions
730
Shares Held
102M
Call Options Held
230K
Put Options Held
477K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email